VEGF (Bevacizumab Biosimilar) Antikörper
(VEGF (Bevacizumab Biosimilar))
This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. [provided by RefSeq, Jul 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene VEGF (Bevacizumab Biosimilar) Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
FACS, in vivo
Validierungen
Kat. Nr.
ABIN7200653
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
ELISA
Validierungen
Kat. Nr.
ABIN7093077
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
FACS, ELISA, BR, IP, WB
Validierungen
Kat. Nr.
ABIN7487763
Menge
200 μg
Datenblatt
Datenblatt
Synonyme und alternative Namen zu VEGF (Bevacizumab Biosimilar)
vascular endothelial growth factor A (VEGFA), MVCD1, VEGF, VPFBezeichner auf Proteinebene für VEGF (Bevacizumab Biosimilar)
- vascular permeability factor
Sie sind hier:
